Table 1

Baseline patient characteristicsa

Unselected (n = 100)Refractory (n = 11)
Median age (years)32 (14–66)29 (18–55)
Histology
 Seminoma501
 Nonseminoma5010
  Mixed nonseminoma297
  Embryonal carcinoma70
  Yolk sac tumor53
  Mature teratoma90
Time of tissue sampling
 At initial diagnosis998
 After chemotherapy13
Systemic treatment
 Standard PE/PEB/PVB/PEINA11
 Salvage high-dose chemotherapyNA7
Median time to progression (months)NA10 (2–149)
Median overall survival (months)NA40 (11–180)
  • a P, cisplatin; E, etoposide; B, bleomycin; V, vinblastine; I, ifosfamide; NA, not available.